Market revenue in 2023 | USD 81.4 million |
Market revenue in 2030 | USD 145.8 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Regenerative medicine |
Fastest growing segment | Drug Discovery & Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regenerative Medicine, Drug Discovery & Development |
Key market players worldwide | Thermo Fisher Scientific Inc, Sartorius Stedim Biotech SA, Element Solutions Inc, PromoCell GmbH, Lonza Group Ltd, LifeCell International, Gilead Sciences Inc, International Stem Cell Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human embryonic stem cells market will help companies and investors design strategic landscapes.
Regenerative medicine was the largest segment with a revenue share of 90.42% in 2023. Horizon Databook has segmented the Germany human embryonic stem cells market based on regenerative medicine, drug discovery & development covering the revenue growth of each sub-segment from 2018 to 2030.
Germany has a large number of institutes and universities which are involved in the adoption of stem cell techniques to serve their research purposes, thereby boosting revenue generation in this country. Moreover, conferences and workshops held in the region regarding human embryonic stem cells technology are expected drive growth.
Although the country has very strict laws and regulatory policies to conduct stem cell research the country encourages research in stem cell for clinical application. For example, in March 2016, about 200 students from the country visited MDC Insights - Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin to attended UniStem Day.
Such initiatives bring together researchers to share their insights for the industry and encourages students’ interest in the field. Frequent presence of such conferences and seminars across the country is expected to increase adoption of hESC techniques.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany human embryonic stem cells market , including forecasts for subscribers. This country databook contains high-level insights into Germany human embryonic stem cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account